| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
The deal aims to accelerate Talicia's entry into new Middle East markets Under the terms of the agreement RedHill will rece...
Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The ...
The New York Supreme Court has, on appeal, upheld its original summary judgment ruling in favor of RedHillThe New York Supreme ...
Redhill Biopharma (NASDAQ:RDHL) reported $4.079 million in sales this quarter. This is a 58.59 percent increase over sales of $...
The positive FDA feedback allows for:A novel Phase 2 RHB-204[1] study, planned to be the first ever clinical study in a specifi...
